Registration
HOLLAND & KNIGHT LLP for IPSEN BIOPHARMACEUTICALS, INC.
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax Reform - Restoring the Orphan Drug Tax Credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA DAVID ODINTZ New | Tax Counsel, Senate Finance Committee |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| IPSEN PHARMA S.A. | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.